Tuesday of the First Week in Ordinary Time Reading 1

New Post Public Reply Private Reply Replies (0) Message Board
Bible Feed
274
Tuesday of the First Week in Ordinary Time

Reading 1 Heb 2:5-12

It was not to angels that God subjected the world to come,
of which we are speaking.
Instead, someone has testified somewhere:

What is man that you are mindful of him,
or the son of man that you care for him?
You made him for a little while lower than the angels;
you crowned him with glory and honor,
subjecting all things under his feet.


In "subjecting" all things to him,
he left nothing not "subject to him."
Yet at present we do not see "all things subject to him,"
but we do see Jesus "crowned with glory and honor"
because he suffered death,
he who "for a little while" was made "lower than the angels,"
that by the grace of God he might taste death for everyone.

For it was fitting that he,
for whom and through whom all things exist,
in bringing many children to glory,
should make the leader to their salvation perfect through suffering.
He who consecrates
and those who are being consecrated all have one origin.
Therefore, he is not ashamed to call them "brothers" saying:

I will proclaim your name to my brethren,
in the midst of the assembly I will praise you.


Responsorial Psalm PS 8:2ab and 5, 6-7, 8-9

R. (see 7) You have given your Son rule over the works of your hands.
O LORD, our Lord,
how glorious is your name over all the earth!
What is man that you should be mindful of him,
or the son of man that you should care for him?
R. You have given your Son rule over the works of your hands.
You have made him little less than the angels,
and crowned him with glory and honor.
You have given him rule over the works of your hands,
putting all things under his feet.
R. You have given your Son rule over the works of your hands.
All sheep and oxen,
yes, and the beasts of the field,
The birds of the air, the fishes of the sea,
and whatever swims the paths of the seas.
R. You have given your Son rule over the works of your hands.

Alleluia 1 Thes 2:13

R. Alleluia, alleluia.
Receive the word of God, not as the word of men,
but as it truly is, the word of God.
R. Alleluia, alleluia.

Gospel Mk 1:21-28

Jesus came to Capernaum with his followers,
and on the sabbath he entered the synagogue and taught.
The people were astonished at his teaching,
for he taught them as one having authority and not as the scribes.
In their synagogue was a man with an unclean spirit;
he cried out, "What have you to do with us, Jesus of Nazareth?
Have you come to destroy us?
I know who you are–the Holy One of God!"
Jesus rebuked him and said, "Quiet! Come out of him!"
The unclean spirit convulsed him and with a loud cry came out of him.
All were amazed and asked one another,
"What is this?
A new teaching with authority.
He commands even the unclean spirits and they obey him."
His fame spread everywhere throughout the whole region of Galilee.
- - -
Lectionary for Mass for Use in the Dioceses of the United States, second typical edition, Copyright © 2001, 1998, 1997, 1986, 1970 Confraternity of Christian Doctrine; Psalm refrain © 1968, 1981, 1997, International Committee on English in the Liturgy, Inc. All rights reserved. Neither this work nor any part of it may be reproduced, distributed, performed or displayed in any medium, including electronic or digital, without permission in writing from the copyright owner.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lilly's Retatrutide Outshines Ozempic in Key Diabetes Trial

Updated Category News Views 24

Lilly's Breakthrough in Diabetes Treatment Eli Lilly's retatrutide is stirring up the diabetes treatment waters. The latest Phase 3 comparison to Ozempic's top dose reveals some surprising results. I'm not one to toss out kudos lightly, but this could be a genuine game-changer if things hold steady. A1C Reductions: A Close Look at the Numbers We’re staring down the...

Continue Reading
Samuel Oschin Air & Space Center Takes Flight This Fall

Updated Category News Views 98

The Grand Unveiling: November Highlights Look at this: space nerds, dreamers, and just about anybody with a heartbeat and a sense of wonder should circle November 13, 2026, like a kid with a candy store gift card. That's when the California Science Center throws open the doors to the Samuel Oschin Air and Space Center. You might as well slap a 'world's first' sticker on...

Continue Reading
Unicycive Faces Legal Heat: Shareholder Lawsuit Looms

Updated Category News Views 104

The Unicycive Landslide: What Went Down? Investors, buckle up. Unicycive Therapeutics Inc. (NASDAQ: UNCY) finds itself deep in the muck of a securities class action. Chief honchos, CEO Shalabh Gupta and CFO John Townsend, are taking the heat for allegedly controlling company disclosures that led shareholders to believe in non-existent progress with their third-party...

Continue Reading
Navigating Gas-to-AI Power: Challenges & Opportunities

Updated Category News Views 83

Natural Gas Abundance Meets Conversion Hurdles It’s a wild scene when you've got oodles of natural gas but struggle to get it into AI data centers. That’s the picture today: U.S. gas production hitting a high of 137 billion cubic feet daily, while converting that gas into practical energy is the real challenge. You see, the gas market is ready to rumble, ticking...

Continue Reading
Ameritas Hires Actuarial Veteran as VP in Strategic Move

Updated Category News Views 115

Shifting Gears at Ameritas: New VP Takes the Helm Well, chalk one up for Ameritas on this move. They've just brought on Ying Zhao as the new vice president of actuarial and financial strategy. It's a mouthful of a title, sure, but it's the role itself that's worth watching. Ameritas, for those not tracking, is a major player in the insurance and financial universe, doing...

Continue Reading
Replay Sports Cards Nets STAR Award for Innovation

Updated Category News Views 82

A New Era for Franchise Onboarding Just when you think the sports card world couldn't get any more niche, along comes Replay Sports Cards thumping its chest with some serious innovation. This Charlotte-based franchise just snagged the Franchise Innovation Award from Franchise Update Media. Yep, they're the only ones getting tips of the hat for the Most Innovative...

Continue Reading
Step into Fear: Dead by Daylight in Moreno Valley

Updated Category News Views 54

Immersive Horror in Moreno Valley Walking straight into the fog of your nightmares isn't for the faint-hearted, but that's the kind of thrill the Moreno Valley Museum & ArtSpace is serving up with its new Dead by Daylight Immersive Experience. Kicking off just in time for Halloween on October 30, this isn't your average stroll in a museum—it's a heart-pounding,...

Continue Reading
Armani/Casa Miami Earns Forbes Designation for Luxury

Updated Category News Views 34

Where Luxury Meets Thoughtfulness Residences by Armani/Casa Miami just nabbed a VERIFIED™ Luxury Residences badge from the Forbes Travel Guide folks. Now, you might be wondering why this is significant or if it's just another shiny tag in a world already glistening with luxury concepts. Well, there's a shift happening here, and it's got some meat to it. The folks...

Continue Reading
South Dakota's BEES Launch: Child Care Assistance Goes Live

Updated Category News Views 24

RedMane and South Dakota DSS: A New Milestone Talk about a leap into the digital age. South Dakota's Department of Social Services, teaming up with RedMane Technology, has just rolled out the Child Care Assistance Program on their BEES platform. That’s Benefits Eligibility and Enrollment System for those not keeping track. It represents a significant step in making life...

Continue Reading
QFIN Faces Lawsuit Over Broken Promises and Revenue Plunge

Updated Category News Views 48

Unmasking the Hype: QFIN's Pledge and Performance Investors, gather 'round because QFIN's latest uproar ain't pretty. The folks over at Qfin Holdings have found themselves in hot water, facing a class action lawsuit for allegedly pulling the wool over investors' eyes. Between March and August 2026, they promised a rock-solid ship braving China’s regulatory storm. Turns...

Continue Reading

Top 5 Most Recently Viewed Articles

BCMGlobal Takes Charge of NFSC's Loan Servicing Evolution

Updated Category News Views 197

BCMGlobal's New Role in Advancing NFSC BCMGlobal has been appointed to strategically manage the National Financing Support Services Company (NFSC), elevating it to a leading independent loan servicer. This initiative aims to promote excellence in the sector. Supporting Saudi Arabia's Financial Vision The NFSC, established with the backing of the Saudi Real Estate...

Continue Reading
Breakthrough MRD Data from Myriad Genetics at Cancer Conference

Updated Category News Views 201

Innovative Insights into MRD Testing Myriad Genetics, Inc. (NASDAQ: MYGN), a prominent name in molecular diagnostics and precision medicine, is set to unveil exciting new clinical findings related to their Precise MRD test at a significant annual meeting dedicated to cancer research. Presentation Highlights During the conference, Dr. Chad Tang from The University of Texas...

Continue Reading
SBM Offshore's Recent Share Buyback Program: Key Insights

Updated Category News Views 119

SBM Offshore's Share Buyback Program Overview SBM Offshore has recently reported on its significant share repurchase program, valued at EUR130 million (approximately US$140 million), covering transactions made from November 21, 2024, to November 27, 2024. This initiative underscores the company’s commitment to enhancing shareholder value through systematic buybacks. Key...

Continue Reading
Investigation into Akero Therapeutics by Berger Montague PC

Updated Category News Views 165

Akero Therapeutics Under Investigation by Berger Montague Berger Montague PC, a respected law firm, recently brought to attention an ongoing investigation into the practices of Akero Therapeutics, Inc. The investigation focuses on potential breaches of fiduciary duties and violations of federal securities laws by Akero’s Board of Directors, which has crucial...

Continue Reading
Nkarta's Upcoming Interactive Session: What to Expect?

Updated Category News Views 127

Nkarta to Engage with Investors in H.C. Wainwright Series Nkarta, Inc. (NASDAQ: NKTX), a pioneering clinical-stage biopharmaceutical firm dedicated to creating innovative engineered natural killer (NK) cell therapies, recently announced its notable role in the H.C. Wainwright "HCW@Home" Series. This virtual series will allow investors and interested parties to gain deeper...

Continue Reading